Found 865 articles for: "acne"
August 2019 | Volume 18 | Issue 8 | Original Article | 756 | Copyright © August 2019
Background: Topical corticosteroids are efficacious treatment options for multiple dermatoses. However, ointments and cream corticosteroid vehicles can be cumbersome to patients and m...
August 2019 | Volume 18 | Issue 8 | Original Article | 718 | Copyright © August 2019
Melasma and postinflammatory hyperpigmentation (PIH) are the most common forms of dyschromia in patients with skin of color. Both are associated with a high psychological burden of disease. To exacerb...
August 2019 | Volume 18 | Issue 8 | Supplement Individual Articles | 187 | Copyright © August 2019
Consumer demand for skin tightening and resurfacing procedures has accelerated during the last several years. Numerous energy-based treatment options have emerged for facial rejuvenation together with...
July 2019 | Volume 18 | Issue 7 | Original Article | 655 | Copyright © July 2019
Background: Impetigo, a bacterial infection that is highly contagious, involves the superficial skin. Topical treatment for impetigo includes amongst other bacitracin, g...
In Vitro and In Vivo Efficacy and Tolerability of a Non-Hydroquinone, Multi-Action Skin Tone Correcting Cream
July 2019 | Volume 18 | Issue 7 | Original Article | 642 | Copyright © July 2019
Background: Pigmentation disorders are therapeutically challenging to treat, requiring complicated regimens.
July 2019 | Volume 18 | Issue 7 | Original Article | 618 | Copyright © July 2019
Background: Misperceptions about facial aesthetic treatments in individuals with skin of color (SOC) may influence treatment selection.Read More
July 2019 | Volume 18 | Issue 7 | Original Article | 608 | Copyright © July 2019
Rosacea is among the most common facial skin conditions diagnosed by dermatologists. Typical clinical features include erythema, flushing, telangiectasia, papules, and pustules distribut...
A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne
June 2019 | Volume 18 | Issue 6 | Original Article | 570 | Copyright © June 2019
Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study
June 2019 | Volume 18 | Issue 6 | Original Article | 563 | Copyright © June 2019
Validation of Botanical Treatment Efficiency for Adults and Children Suffering from Mild to Moderate Atopic Dermatitis
June 2019 | Volume 18 | Issue 6 | Original Article | 557 | Copyright © June 2019
Objective: The study was conducted to determine the efficiency of the botanicals combination incorporated in the Kamedis Eczema Therapy Cream (the tested product) for adults and child...
June 2019 | Volume 18 | Issue 6 | Original Article | 550 | Copyright © June 2019
Background: Treatment of scars continues to be a persisting challenge. Scar classification is paramount in determining an appropriate treatment strategy. They can be classified into h...
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris
June 2019 | Volume 18 | Issue 6 | Original Article | 542 | Copyright © June 2019
Background: Tazarotene has been extensively studied in clinical trials and is widely used to treat acne vulgaris (acne). Irritation potential has limited its use.
June 2019 | Volume 18 | Issue 6 | Original Article | 522 | Copyright © June 2019
Background: Anecdotal reports indicate the use of microfocused ultrasound with visualization (MFU-V) improves facial redness.
Objective: The purpose of th...
Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study
June 2019 | Volume 18 | Issue 6 | Original Article | 514 | Copyright © June 2019
Background: Patients with skin of color (SOC) and Fitzpatrick skin types (FST) IV–VI frequently develop acne.
Objective: Evaluate subject-reported o...
June 2019 | Volume 18 | Issue 6 | Original Article | 506 | Copyright © June 2019
Rosacea is common inflammatory facial dermatosis. Rosacea has variable manifestations including facial flushing, central facial erythema, telangiectasias, and papulopustular lesions. Treatment of rosa...
June 2019 | Volume 18 | Issue 6 | Editorials | 503 | Copyright © June 2019
With all the literature and research we have on acne and rosacea, there are still many unanswered questions. Over time, as we uncover more information on both preexisting and newly recog...
Life of a Wound: Serial Documentation of Wound Healing After Shave Removal Using Reflectance Confocal Microscopy
May 2019 | Volume 18 | Issue 5 | Case Reports | 472 | Copyright © May 2019
Reflectance Confocal Microscopy (RCM) is a new noninvasive skin imaging modality that is comparable to traditional histopathology. We present serial in vivo RCM imaging of an atypical nevus after shav...
Optimizing Patient Outcomes by Customizing Treatment With Microfocused Ultrasound With Visualization: Gold Standard Consensus Guidelines from an Expert Panel
May 2019 | Volume 18 | Issue 5 | Original Article | 426 | Copyright © May 2019
Background: Microfocused ultrasound with visualization (MFU-V) has emerged as a safe and reliable means for lifting and tightening lax skin. Although patients may present with similar age-related chan...
Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro
May 2019 | Volume 18 | Issue 5 | Original Article | 412 | Copyright © May 2019
Cortexolone 17α-propionate (clascoterone) is a novel topical androgen antagonist that is being analyzed for its ability to treat acne. The pathogenesis of acne is attributed to multiple factors,...
April 2019 | Volume 18 | Issue 4 | Department | 146 | Copyright © April 2019
The history of tretinoin and its use in dermatology is a testament both to the drug’s well-established efficacy and its potential to cause skin irritation. Over more than four decades, the drug ...